Ulrike Keim

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · The Lancet Oncology · 2016 · 684 citations

Surgical Oncology, Medicine, Surgical Pathology +7

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · Journal of Clinical Oncology · 2019 · 236 citations

Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany

Ulrike Leiter, Ulrike Keim, Thomas Eigentler et al. · Journal of Investigative Dermatology · 2017 · 225 citations

Nonmelanoma Skin Cancer, Cancer Epidemiology, Medicine +8

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study

Andrea Forschner, Florian Battke, Dirk Hadaschik et al. · Journal for ImmunoTherapy of Cancer · 2019 · 202 citations · Full text

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

Claus Garbe, Ulrike Keim, Sara Gandini et al. · European Journal of Cancer · 2021 · 140 citations

White Populations 1943–2036, Cancer Epidemiology, Medicine +9